Eugenia has over 15 years of research and consulting to the pharmaceutical industry, with a particular expertise in modelling, meta-analysis and regulatory and HTA engagement, as well as evidence generation planning to support MA. She led a broad range of HEOR projects in various indications, including oncology, chronic obstructive pulmonary disease, and multiple sclerosis, as well facilitated preparation for and moderated numerous advisory boards.
Prior to joining Huron, Eugenia worked at London School of Hygiene and Tropical Medicine and Evidera. Her responsibilities included strategic project management of research projects in various indications, including oncology, chronic obstructive pulmonary disease, and multiple sclerosis, as well as developing literature and health technology assessment review protocols, handling other study design elements, providing support in economic model development, and conducting statistical or other analyses.
She has also facilitated preparation for and moderated numerous advisory boards. She has over 15 years’ experience in health economics and outcomes research and has worked on clinical guideline development in oncology in collaboration with the National Collaborating Centre for Cancer (NCC-C) and the National Institute for Health and Clinical Excellence. Her previous work also includes evaluation of the verteporfin Photodynamic Therapy Cohort Study for the UK and analysis of longitudinal datasets. She was also a seminar leader for basic statistics and economic evaluation modules.
- Life Sciences
HEOR/ Value Communication/ Evidence Generation/ Expert Opinion Elicitation and Formal HTA Engagement
- Life Sciences
BA/MA, Economics, Hunter College
CUNY Certificate, Health Economics, University of York